Jan 11 (Reuters) - Esperion Therapeutics Inc ESPR.O:
ESPERION PROVIDES BUSINESS UPDATE AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
ESPERION THERAPEUTICS INC - REPORTS $156 TO $160 MILLION IN PRELIMINARYFULL-YEAR 2025 U.S. NET PRODUCT SALES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.